Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jeremy Weleff

Biographic Data

ID1754459
NAMEJeremy Weleff
GIVEN NAMESJeremy
FAMILY NAMEWeleff
SIGNATUREWELEFF J
AFFILIATIONSYale University
ORCID0000-0001-8071-7412
VERIFIEDYes
TOTAL WORKS10
TOTAL CITATIONS0
AUTHOR COUNT10
EDITOR COUNT0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Policy recommendations for overdose response hotlines and applications as a harm reduction tool

    Open Access•William Rioux, Nathan Rider et al.•ARTICLE•Canadian Journal of Public Health•2026•References: 29

    To enhance the effectiveness and sustainability of overdose response technologies, a comprehensive policy or standards framework is needed. This includes guidance on data privacy, service equity, public education, capacity-building, and outcome evaluation, laying the groundwork for safer, scalable, and more accessible overdose prevention interventions

  • Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy

    Brian S Barnett, Miranda Arakelian et al.•ARTICLE•Journal of Psychoactive Drugs•2025

    This study evaluated the attitudes, knowledge, and educational experiences of psychiatry residents regarding psychedelics and psychedelic-assisted therapy (PAT). In 2023, we distributed an anonymous survey to United States psychiatry residents, assessing demographics, knowledge, and opinions on psychedelics/PAT. The survey also included items asking respondents to retrospectively self-report how strongly psychedelic-related work and educational o…

  • Why Harm Reduction and Equity Are Ethical Imperatives in Opioid Use Disorder Care

    Open Access•Jeremy Weleff•ARTICLE•The AMA Journal of Ethic•2024

  • Adverse Childhood Experiences (ACEs) in Unhoused Children Increase Odds of Psychiatric Illness, Physical Illness, and Psychiatric Admission

    Open Access•Eric J Pan, Jessie Liu et al.•ARTICLE•Journal of Child & Adolescent…•2024

  • LSD use in the United States

    Open Access•Jeremy Weleff, Akhil Anand et al.•ARTICLE•Journal of Psychedelic Studies•2024

    BackgroundLysergic acid diethylamide (LSD) use has risen in the United States in recent years amid increased interest in therapeutic applications of psychedelics. Despite this, contemporary epidemiological investigations of LSD users are few. To expand the literature on this topic, we sought to characterize past-year LSD users in the United States and investigate recent demographic evolution within this population.MethodsUsing National Survey on …

  • Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD

    Alexsandra Kovacevich, Jeremy Weleff et al.•ARTICLE•Journal of Psychoactive Drugs•2023

    Cultural awareness of anosmia and microsmia has recently increased due to their association with COVID-19, though treatment for these conditions is limited. A growing body of online media claims that individuals have noticed improvement in anosmia and microsmia following classic psychedelic use. We report what we believe to be the first three cases recorded in the academic literature of improvement in olfactory impairment after psychedelic use. I…

  • An Analysis of Benzodiazepine Prescribing to Primary Care Patients in a Large Healthcare System from 2019-2020

    Jeremy Weleff, Akhil Anand et al.•ARTICLE•Journal of Psychoactive Drugs•2023

    We sought to quantify benzodiazepine prescribing by primary care providers from 2019 to 2020 and identify correlates of prescribing. We hypothesized prescribing would increase post-COVID-19 lockdown. We conducted a retrospective cohort study of adult patients with primary care visits in 2019 or 2020 in a large Ohio healthcare system. Demographics, diagnosis codes, and receipt of benzodiazepine prescriptions were collected. Using multivariable log…

  • With Stillness and Solidarity

    Open Access•Jeremy Weleff•ARTICLE•The AMA Journal of Ethic•2022

  • United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020

    Open Access•Brian S Barnett, Sloane E Parker et al.•ARTICLE•International Journal of Drug…•2022

  • Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies

    Jeremy Weleff, Teddy J Akiki et al.•ARTICLE•Journal of Psychoactive Drugs•2022

    Following a decades long period of investigational dormancy, there is renewed interest in employing psychedelics as psychiatric treatments. The academic journals, institutions, and countries that have helped sustain clinical psychedelic research and the evolution of the literature on clinical studies of psychedelics have only recently begun to be investigated. To expand upon this work, we conducted a bibliometric analysis of clinical studies of 5…

No prominent works on this page.

  • With Stillness and Solidarity

    Open Access•Jeremy Weleff•ARTICLE•The AMA Journal of Ethic•2022

  • United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020

    Open Access•Brian S Barnett, Sloane E Parker et al.•ARTICLE•International Journal of Drug…•2022

  • Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies

    Jeremy Weleff, Teddy J Akiki et al.•ARTICLE•Journal of Psychoactive Drugs•2022

    Following a decades long period of investigational dormancy, there is renewed interest in employing psychedelics as psychiatric treatments. The academic journals, institutions, and countries that have helped sustain clinical psychedelic research and the evolution of the literature on clinical studies of psychedelics have only recently begun to be investigated. To expand upon this work, we conducted a bibliometric analysis of clinical studies of 5…

  • Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD

    Alexsandra Kovacevich, Jeremy Weleff et al.•ARTICLE•Journal of Psychoactive Drugs•2023

    Cultural awareness of anosmia and microsmia has recently increased due to their association with COVID-19, though treatment for these conditions is limited. A growing body of online media claims that individuals have noticed improvement in anosmia and microsmia following classic psychedelic use. We report what we believe to be the first three cases recorded in the academic literature of improvement in olfactory impairment after psychedelic use. I…

  • An Analysis of Benzodiazepine Prescribing to Primary Care Patients in a Large Healthcare System from 2019-2020

    Jeremy Weleff, Akhil Anand et al.•ARTICLE•Journal of Psychoactive Drugs•2023

    We sought to quantify benzodiazepine prescribing by primary care providers from 2019 to 2020 and identify correlates of prescribing. We hypothesized prescribing would increase post-COVID-19 lockdown. We conducted a retrospective cohort study of adult patients with primary care visits in 2019 or 2020 in a large Ohio healthcare system. Demographics, diagnosis codes, and receipt of benzodiazepine prescriptions were collected. Using multivariable log…

  • Why Harm Reduction and Equity Are Ethical Imperatives in Opioid Use Disorder Care

    Open Access•Jeremy Weleff•ARTICLE•The AMA Journal of Ethic•2024

  • Adverse Childhood Experiences (ACEs) in Unhoused Children Increase Odds of Psychiatric Illness, Physical Illness, and Psychiatric Admission

    Open Access•Eric J Pan, Jessie Liu et al.•ARTICLE•Journal of Child & Adolescent…•2024

  • LSD use in the United States

    Open Access•Jeremy Weleff, Akhil Anand et al.•ARTICLE•Journal of Psychedelic Studies•2024

    BackgroundLysergic acid diethylamide (LSD) use has risen in the United States in recent years amid increased interest in therapeutic applications of psychedelics. Despite this, contemporary epidemiological investigations of LSD users are few. To expand the literature on this topic, we sought to characterize past-year LSD users in the United States and investigate recent demographic evolution within this population.MethodsUsing National Survey on …

  • Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy

    Brian S Barnett, Miranda Arakelian et al.•ARTICLE•Journal of Psychoactive Drugs•2025

    This study evaluated the attitudes, knowledge, and educational experiences of psychiatry residents regarding psychedelics and psychedelic-assisted therapy (PAT). In 2023, we distributed an anonymous survey to United States psychiatry residents, assessing demographics, knowledge, and opinions on psychedelics/PAT. The survey also included items asking respondents to retrospectively self-report how strongly psychedelic-related work and educational o…

  • Policy recommendations for overdose response hotlines and applications as a harm reduction tool

    Open Access•William Rioux, Nathan Rider et al.•ARTICLE•Canadian Journal of Public Health•2026•References: 29

    To enhance the effectiveness and sustainability of overdose response technologies, a comprehensive policy or standards framework is needed. This includes guidance on data privacy, service equity, public education, capacity-building, and outcome evaluation, laying the groundwork for safer, scalable, and more accessible overdose prevention interventions

Medicine (7 works) · Psychiatry (7 works) · Internal Medicine (5 works) · Psychedelics and Drug Studies (5 works) · Psychology (5 works) · Hallucinogen (4 works) · Psilocybin (4 works) · Chemical synthesis and alkaloids (3 works) · Political science (3 works) · Sociology (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae